HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A H Friedman Selected Research

Monoclonal Antibodies

11/2000Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
6/2000Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.
3/2000Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A H Friedman Research Topics

Disease

6Glioma (Gliomas)
12/2009 - 03/2000
4Neoplasms (Cancer)
09/2004 - 06/2000
3Glioblastoma (Glioblastoma Multiforme)
10/2012 - 01/2000
2Hypertension (High Blood Pressure)
12/2009 - 01/2000
2Disease Progression
10/2001 - 05/2000
2Brain Neoplasms (Brain Tumor)
06/2000 - 03/2000
1Hypoxia (Hypoxemia)
12/2009
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2009
1Neurofibrosarcoma (MPNST)
09/2004
1Neurofibroma
09/2004
1Chest Pain (Chest Pains)
09/2004
1Hodgkin Disease (Hodgkin's Disease)
09/2004
1Horner Syndrome (Horner's Syndrome)
09/2004
1Radiculopathy (Radiculopathy, Cervical)
09/2004
1Lymphoma (Lymphomas)
09/2004
1Seizures (Absence Seizure)
11/2001
1Muscular Atrophy (Muscle Atrophy)
09/2001
1Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
09/2001
1Hypercalcemia (Milk Alkali Syndrome)
08/2001
1Hyperparathyroidism
08/2001
1Hypophosphatemic Rickets
08/2001
1Bilateral Hearing Loss
05/2001
1Melanoma (Melanoma, Malignant)
05/2001
1Meningitis
05/2001
1Neutropenia
10/2000
1Thrombocytopenia (Thrombopenia)
10/2000
1Status Epilepticus (Complex Partial Status Epilepticus)
07/2000
1Pathologic Processes
06/2000
1Experimental Melanoma
06/2000
1Hemorrhage
01/2000
1Edema (Dropsy)
01/2000
1Cerebral Hemorrhage
01/2000

Drug/Important Bio-Agent (IBA)

3Monoclonal AntibodiesIBA
11/2000 - 03/2000
2Bevacizumab (Avastin)FDA Link
10/2012 - 12/2009
2Anticonvulsants (Antiepileptic Drugs)IBA
11/2001 - 07/2000
2Temozolomide (Temodar)FDA LinkGeneric
10/2001 - 10/2000
2ErbB Receptors (EGF Receptor)IBA
06/2000 - 01/2000
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2009
1Carbonic Anhydrase IXIBA
12/2009
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
10/2001
1Genetic Markers (Genetic Marker)IBA
09/2001
1CalciumIBA
08/2001
1Phosphorus (Red Phosphorus)IBA
08/2001
1Proteoglycans (Proteoglycan)IBA
05/2001
1Sulfates (Sulfates, Inorganic)IBA
05/2001
1Iodine-131IBA
11/2000
1O(6)-benzylguanineIBA
10/2000
1Carmustine (FIVB)FDA Link
10/2000
1EpitopesIBA
06/2000
1Immunoglobulin G (IgG)IBA
06/2000
1AntigensIBA
06/2000
1epidermal growth factor receptor VIIIIBA
06/2000
1AntibodiesIBA
05/2000
1TenascinIBA
03/2000
1Nicardipine (Dagan)FDA LinkGeneric
01/2000
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
01/2000

Therapy/Procedure

5Therapeutics
10/2012 - 03/2000
4Drug Therapy (Chemotherapy)
12/2009 - 11/2000
3Radiotherapy
09/2004 - 05/2001
2Aftercare (After-Treatment)
10/2001 - 05/2001
2Neurosurgical Procedures
07/2000 - 01/2000
1Length of Stay
04/2009
1Laminectomy
09/2004
1Immunotherapy
06/2000
1Injections
03/2000